EUVIMEDEUVIMED entdecken
Crossref

Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors

Feyzi Sinan Tokalı iD, Yeliz Demir iD, Cüneyt Türkeş, Büşra Dinçer, Şükrü Beydemir

Drug Development Research · 2023-04 · 84 (2) · 275-295

DOI: 10.1002/ddr.22031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 04.01.2023. Verfasst von Feyzi Sinan Tokalı und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Turkey. Hauptthemen laut MEDLINE: Acetic Acid, Aldehyde Reductase. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 120 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aldose reductase (AR) is a crucial enzyme of the polyol pathway through which glucose is metabolized under conditions of hyperglycemia related to diabetes. A series of novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring ( 1–22 ) was synthesized and tested for in vitro AR inhibitory effect. All the target compounds exhibited nanomolar activity against the target enzyme, and all compounds displayed higher activity as compared to the reference drug epalrestat. Among them, Compound 19 , named 2‐(4‐[(2‐[(4‐methylpiperazin‐1‐yl)methyl]‐4‐oxoquinazolin‐3(4 H )‐ylimino)methyl]phenoxy)acetic acid, displayed the strongest inhibitory effect with a K I value of 61.20 ± 10.18 nM. Additionally, these compounds were investigated for activity against L929, nontumoral fibroblast cells, and MCF‐7, breast cancer cells using the MTT assay. Compounds 16 and 19 showed lower toxicity against the normal L929 cells. The synthesized compounds’ ( 1–22 ) absorption, distribution, metabolism, and excretion properties were also evaluated. Molecular docking simulations were used to look into the possible binding mechanisms of these inhibitors against AR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acetic AcidAldehyde ReductaseEnzyme InhibitorsMolecular Docking SimulationStructure-Activity RelationshipHumansFemale

Stichwörter der Autor:innen

ADMEaldose reductasemolecular dockingquinazolinessynthesis

Substanzen

Acetic AcidAldehyde ReductaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Turkey.
  • Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Turkey.
  • Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey.
  • Department of Pharmacology, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey.
  • Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
  • The Rectorate of Bilecik Şeyh Edebali University, Bilecik, Turkey.

ORCID-Profile: Feyzi Sinan Tokalı, Yeliz Demir

Zitieren

APA

Tokalı, F. S., Demir, Y., Türkeş, C., Dinçer, B., & Beydemir, Ş. (2023). Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Drug Development Research, 84(2), 275-295. https://doi.org/10.1002/ddr.22031

Vancouver

Tokalı FS, Demir Y, Türkeş C, Dinçer B, Beydemir Ş. Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors. Drug Development Research. 2023;84(2):275-295. doi:10.1002/ddr.22031

BibTeX
@article{Tokal2023,
  author = {Tokalı, Feyzi Sinan and Demir, Yeliz and Türkeş, Cüneyt and Dinçer, Büşra and Beydemir, Şükrü},
  title = {Novel acetic acid derivatives containing quinazolin‐4(3 H )‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors},
  journal = {Drug Development Research},
  year = {2023},
  volume = {84},
  number = {2},
  pages = {275--295},
  doi = {10.1002/ddr.22031}
}
Kostenlos starten →